U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. FDA Technology Transfer Program
  4. Licensing and Collaboration Opportunities
  5. Software for Evaluating Drug Induced Hepatotoxicity
  1. Licensing and Collaboration Opportunities

Software for Evaluating Drug Induced Hepatotoxicity

Download the Abstract (PDF - 92KB)

Technology Summary

The detection and assessment of drug induced liver disease has emerged as a challenging task due to the low incidence of findings and the burdensome work of searching through massive quantities of data sets. A method to assist medical diagnosis to identify sometimes rare but serious cases of drug induced liver disease is of interest.

To address this issue, FDA researchers have created a software tool for assisting differential medical diagnosis of drug-induced liver injury (hepatotoxicity) using clinical trial data. The software can identify a small subset of patients at risk for hepatotoxicity out of a pool of thousands of clinical trial participants. This software tool is the only one of its kind developed using SAS/IntrNet®.

Potential Commercial Applications

  • Hepatotoxicity detection
  • Drug interactions

Competitive Advantages

  • Personalized predictions
  • SAS/IntrNet® compatible

Development Stage: Software Tool - Patent protection is not being pursued for this technology.

Inventors:
Ted Guo

Publications:
Guo T, et al. A Tool to Help You Decide [detect potentially serious liver injury]. Silver Spring, Maryland: Presentation at the Annual Conference of the American Association for the Study of Liver Diseases, 2008. PMID 21332248

Guo T, et al. How a SAS/IntrNet tool was created at the FDA for the detection of potential drug-induced liver injury using data with CDISC standard. San Diego, California: Proceedings of the Western Users of SAS Software Annual Conference, 2009.

Product Area: Software

FDA Reference No: E-2012-008

Licensing Contact:
Ken Millburne, J.D.
FDA Technology Transfer Program
Email: FDAInventionlicensing@fda.hhs.gov
Phone: 240-402-2245

 

Back to Top